Integrative and Holistic Ophthalmology Podcast, Netra Eye Institute

About Integrative and Holistic Ophthalmology Podcast, Netra Eye Institute

The Netra Eye Institute Podcast is dedicated to advancing the understanding of chronic eye diseases through evidence-informed discussions on integrative ophthalmology, Traditional Chinese Medicine (TCM), Ayurveda, ocular neuroscience, and emerging vision research. Hosted by Dr. Saikumar Gandapodi, each episode examines the underlying mechanisms that contribute to vision loss and visual dysfunction, including ocular blood flow impairment, neurotrophin deprivation, oxidative stress, chronic inflammation, ferroptosis, mitochondrial dysfunction, excitotoxicity, and neurodegeneration. The podcast features: In-depth reviews of current ophthalmic research Discussions on glaucoma, macular degeneration, diabetic retinopathy, retinitis pigmentosa, keratoconus, myopia, optic neuropathies, and other chronic eye disorders Analysis of emerging therapies and integrative treatment approaches Perspectives on Traditional Chinese Medicine and Ayurvedic ophthalmology Interviews with researchers, clinicians, and experts in vision science Patient education on preserving vision and supporting long-term ocular health Critical examination of areas where conventional ophthalmology may have limitations in addressing the broader biological drivers of disease progression. The goal of the podcast is to bridge the gap between conventional ophthalmology, functional medicine, neuroscience, and traditional healing systems while providing patients, practitioners, and researchers with practical, science-based insights into eye health and vision restoration.

Publisher

Dr. Saikumar Gandapodi DAOM, Dipl. OM, L.Ac.

Category

health & fitness · health & fitness · health & fitness

Language

en

Explicit

No

First episode

5 Jul 2026

Latest episode

16 Jul 2026

Latest episodes

12 episodes in the feed.

1. 

   16 Jul 2026

   Glaucoma Beyond Intraocular Pressure: A Multifactorial Neurodegenerative Disease

   Glaucoma has long been treated as a plumbing problem — too much pressure inside the eye. But a growing body of research reframes it as a slow neurodegenerative disease of the optic nerve, where intraocular pressure is one important driver among several. In this episode, Dr. Saikumar Gandapodi joins us to unpack what that shift means for patients. We explore why some people keep losing vision even when their pressure looks controlled, and what the evidence actually shows about ocular blood flow, mitochondrial stress, and the survival of retinal ganglion cells. Dr. Gandapodi explains Netra Restoration Therapy as an integrative, adjunct approach built around neuroprotection and whole-person care. Throughout, the conversation stays grounded: what's established, what's still emerging, and where lowering pressure remains the foundation of care. This is a research-driven look at where glaucoma treatment may be heading.

2. 

   16 Jul 2026

   Retinal and Optic Nerve Resilience: A New Framework for Chronic Eye Disease Management

   Chronic diseases of the retina and optic nerve — glaucoma, certain macular and vascular retinopathies, optic neuropathies — often progress slowly and quietly, even when pressure or blood sugar looks controlled on paper. Why does damage sometimes continue, and what determines whether these delicate neural tissues hold up over time? In this episode, Dr. Saikumar Gandapodi joins the show to explore the concept of tissue resilience: the biology that lets retinal ganglion cells and the optic nerve withstand stress. We unpack the mechanisms that genuinely matter for these tissues — ocular blood flow and vascular dysregulation, mitochondrial energy demand, oxidative stress, neurotrophin biology, and low-grade inflammation — and separate what's well established from what's still emerging. Dr. Gandapodi explains Netra Restoration Therapy as a multi-target, adjunctive framework meant to complement, never replace, standard ophthalmic care. Throughout, the conversation stays evidence-honest: lab findings are distinguished from animal work and from human trials, herbal and traditional-medicine concepts are translated through modern network pharmacology, and no cures are promised. This is a thoughtful look at where conventional care is strong, where it has limits, and where complementary strategies may add value.

3. 

   15 Jul 2026

   Ayurvedic Ophthalmology - Classical Foundations and Modern Evidence

   In this episode, we sit down with Dr. Saikumar Gandapodi, Board-Certified Doctor of Oriental Medicine, Ayurvedic practitioner, and Founder and Director of Netra Eye Institute, to explore the tradition of Ayurvedic ophthalmology. We trace its classical roots in texts like the Sushruta Samhita, and then hold those ideas up against the standards of modern evidence. Dr. Gandapodi explains how ancient concepts such as the doshas and Rakta Dhatu can serve as interpretive frameworks rather than literal biology, and how a handful of Ayurvedic botanicals are now being studied for oxidative stress and ocular surface health. He is candid about the limits of the current evidence, distinguishing laboratory findings from animal work from real human clinical trials. We also discuss Netra Restoration Therapy, an integrative approach he frames strictly as a complement to standard ophthalmic care, and what an educated patient should take away when weighing tradition against trials.

4. 

   9 Jul 2026

   Photobiomodulation in Ophthalmology: Mechanisms and Clinical Evidence

   Photobiomodulation, or PBM, uses low-level red and near-infrared light to influence cellular energy production. In ophthalmology, it's being studied most seriously for retinal conditions like dry age-related macular degeneration, where mitochondrial stress in the retina and RPE plays a central role. In this episode, Dr. Saikumar Gandapodi walks through the biology — how light interacts with cytochrome c oxidase, why the retina is uniquely metabolically demanding, and what recent human trials do and don't tell us. We separate the established from the emerging at every turn. Dr. Gandapodi is candid about the limits: PBM is not a cure, dosing is still being worked out, and much of the mechanistic story comes from lab and animal models. He also explains how PBM fits into an integrative, whole-person framework at Netra Eye Institute — always as an adjunct to standard ophthalmic care, never a replacement. This is a research-driven conversation for anyone curious about where light-based therapy is genuinely heading in eye medicine, and how to think critically about early but promising science.

5. 

   8 Jul 2026

   Integrative Ophthalmology: Defining an Emerging Clinical Discipline

   Where systems biology, root-cause thinking, and standard eye care meet. What does it actually mean to practice integrative ophthalmology, and how is it different from the eye care most patients already know? In this episode, Dr. Saikumar Gandapodi, Board-Certified Doctor of Oriental Medicine, Ayurvedic practitioner, and Founder of Netra Eye Institute, sits down to define an emerging clinical discipline that treats the eye as part of the whole body rather than an isolated organ. We explore where conventional ophthalmology excels, where chronic eye disease leaves gaps, and how concepts like ocular blood flow, oxidative stress, inflammation, and the gut-eye axis are being studied as contributors to disease. Dr. Gandapodi explains Netra Restoration Therapy as a multi-target, adjunctive approach, and he is candid throughout about what is established versus what remains early and hypothesis-generating. This is a research-driven conversation for an educated audience curious about the future of eye health, told without hype and without dismissing the surgery and pharmaceuticals that save sight every day.

6. 

   7 Jul 2026

   Age-Related Macular Degeneration as a Disease of Retinal Metabolic Failure

   Age-related macular degeneration is usually described as a problem of aging and drusen. But a growing body of research points to something deeper: a slow failure of energy metabolism in the retina and the cells that support it. In this episode, Dr. Saikumar Gandapodi, Founder and Director of Netra Eye Institute, reframes AMD as a disease of metabolic exhaustion in the retinal pigment epithelium and photoreceptors. We explore why the macula is metabolically the most demanding tissue in the body, how mitochondrial dysfunction, oxidative stress, and lipid handling failures set the stage for drusen and cell death, and what conventional care does well. Dr. Gandapodi explains the evidence behind anti-VEGF therapy and the AREDS trials, and where meaningful gaps remain. He also introduces Netra Restoration Therapy, an integrative, adjunct approach aimed at supporting mitochondrial function, oxidative balance, and ocular blood flow. Throughout, the conversation stays honest about what is established, what is emerging, and what remains hypothesis.

7. 

   5 Jul 2026

   Neuroprotective Strategies in Glaucoma: Current Evidence and Future Directions

   Glaucoma is often described as a pressure disease, but at its core it's a disease of dying nerve cells. In this episode, Dr. Saikumar Gandapodi joins us to unpack what neuroprotection really means in glaucoma, why lowering eye pressure remains the foundation of care, and where the gaps in that approach open the door for adjunct strategies. We explore the biology of retinal ganglion cell loss, the roles of ocular blood flow, mitochondrial function, oxidative stress, and neurotrophin decline, and what the human evidence actually supports versus what remains hypothesis. Dr. Gandapodi also explains how his integrative framework, Netra Restoration Therapy, is intended to complement conventional treatment rather than replace it. This is a candid, evidence-informed conversation for anyone who wants to understand where glaucoma care is heading and how to think clearly about promise versus proof.

8. 

   5 Jul 2026

   Diabetic Retinopathy, Beyond VEGF, A Neurovascular Disease

   Diabetic retinopathy has long been treated as a disease of leaky, fragile blood vessels, with anti-VEGF injections as a cornerstone of care. But a growing body of research suggests the story starts earlier — in the retina's neurons and glia — well before the classic vascular signs appear. In this episode, Dr. Saikumar Gandapodi joins us to unpack what it means to view diabetic retinopathy as a neurovascular disease. We explore the unit that links neurons, glia, and vessels, why anti-VEGF therapy is powerful yet incomplete, and where mechanisms like oxidative stress, chronic inflammation, and neurotrophin decline may fit. Dr. Gandapodi explains how the Netra Restoration Therapy framework approaches the eye as part of a whole metabolic system — always as a complement to, never a replacement for, standard ophthalmic care. Throughout, we stay honest about the evidence: separating what's established from what's still emerging, distinguishing lab and animal work from human trials, and focusing on what patients living with diabetes can actually take away today.

9. 

   5 Jul 2026

   Beyond Cross-Linking - Ocular Inflammation A New Way of Thinking About Keratoconus

   For decades, keratoconus was described as a purely mechanical, non-inflammatory thinning of the cornea. That story is changing. A growing body of research points to enzymatic activity, oxidative stress, and inflammatory mediators in the tears of people with keratoconus, alongside the mechanical instability that corneal cross-linking is designed to halt. In this episode, host Maya Rao sits down with Dr. Saikumar Gandapodi, Board-Certified Doctor of Oriental Medicine, Ayurvedic practitioner, and Founder of Netra Eye Institute, to explore what the evidence actually supports about the biology of keratoconus. They discuss the enduring value of cross-linking, the role of eye rubbing and the ocular surface, and where integrative, adjunct strategies might complement standard care. Throughout, the conversation stays grounded: established science is separated from emerging hypotheses, no cures are promised, and integrative approaches are framed only as complements to proven ophthalmic treatment.

10. 

    5 Jul 2026

    Normal-Tension Glaucoma and Flammer Syndrome: Current Evidence

    Normal-tension glaucoma challenges the old idea that glaucoma is simply a disease of high eye pressure. In this episode, Dr. Saikumar Gandapodi joins us to unpack what the evidence actually shows about optic nerve damage occurring at statistically normal intraocular pressures, and why blood flow, vascular regulation, and systemic factors matter so much here. We explore Flammer syndrome, a described pattern of vascular dysregulation that shows up in some patients with normal-tension glaucoma, and separate what is established from what is still emerging. Dr. Gandapodi explains how conventional pressure-lowering care remains the proven foundation, and where careful, evidence-informed integrative support may complement it. This is a research-driven conversation for an educated audience curious about the future of eye care. No cures are promised. Instead, we look honestly at the science of neuroprotection, ocular perfusion, and whole-person care around a condition that still keeps clinicians humble.

11. 

    5 Jul 2026

    Ocular Blood Flowåand Vascular Dysregulation in Glaucoma Progression

    Glaucoma has long been defined by intraocular pressure — but a growing body of research shows that many patients continue to lose vision even when their pressure is beautifully controlled. Why? In this episode, host Priya Menon sits down with Dr. Saikumar Gandapodi, Board-Certified Doctor of Oriental Medicine, practitioner of Ayurvedic Medicine, and Founder and Director of Netra Eye Institute, to explore one of the most compelling frontiers in modern eye care: ocular blood flow and vascular dysregulation. Together they unpack the science of optic nerve perfusion, endothelial dysfunction, Flammer Syndrome, oxidative stress, mitochondrial fragility, and the neurotrophic decline that leaves retinal ganglion cells vulnerable. Dr. Gandapodi translates concepts from vascular biology, functional medicine, and network pharmacology into an accessible framework — explaining where conventional, pressure-focused management is powerful, where it can fall short, and where adjunct, systems-based strategies may add value. This is not a conversation about replacing surgery or medication. It is an evidence-informed exploration of the broader biological environment surrounding the optic nerve — from the gut-eye axis to Ginkgo biloba trials — and how Netra Restoration Therapy approaches glaucoma as a multifactorial, whole-person condition. Balanced, rigorous, and forward-looking, this episode is essential listening for patients and clinicians alike.

12. 

    5 Jul 2026

    Keratoconus - An Inflammatory Disease in Disguise

    For decades, textbooks defined keratoconus as a 'non-inflammatory' degenerative thinning of the cornea. But a growing body of peer-reviewed research is challenging that assumption, revealing elevated inflammatory cytokines, oxidative stress, mitochondrial dysfunction, and altered protease activity in the tears and corneal tissue of affected patients. In this episode, host Maya Iyer sits down with Dr. Saikumar Gandapodi, Board-Certified Doctor of Oriental Medicine, Ayurvedic practitioner, and Founder and Director of Netra Eye Institute, to explore why keratoconus may be far more of an inflammatory and systemic disease than its classic definition suggests. Together they trace the mechanistic story — from matrix metalloproteinases and IL-6 and TNF-alpha in tear film, to reactive oxygen species, glutathione depletion, and the biomechanical collapse of collagen crosslinks. Dr. Gandapodi explains where conventional pillars like corneal crosslinking, rigid contact lenses, and transplantation excel, and where adjunct opportunities may exist to address the underlying biological terrain, including the gut-eye axis, eye rubbing, atopy, and oxidative burden. The conversation introduces Netra Restoration Therapy (NRT) as an integrative, complementary framework — never a replacement for standard care — and interprets traditional herbal medicine through the modern lenses of network pharmacology and systems biology. Balanced, evidence-aware, and intellectually honest, this episode is for clinicians, patients, and curious minds who want to understand keratoconus not as an isolated corneal shape problem, but as a whole-person biological process.

Contact Integrative and Holistic Ophthalmology Podcast, Netra Eye Institute

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.